Co-Diagnostics, Inc. to Participate in Gilmartin Group Annual Emerging Growth Showcase on Sept 21
- S&P, Nasdaq slip as caution prevails ahead of Powell comments
- Santa will continue to deliver - Stock Trader's Almanac
- 5 Tesla analysts weigh in as Tesla stock lags after Cybertruck updates
- Shares rally as investor confidence in Fed cuts grows
- Ulta Beauty lifts guidance after Q3 results beat estimates
The Co-Dx PCR Home platform is subject to FDA review and is not available for sale.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a
View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-participate-in-gilmartin-group-annual-emerging-growth-showcase-on-sept-21-301934872.html
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- USCIS Awards Civitas Central Regional Center I-956 Approval, Covering Four States
- AM Best Affirms Credit Ratings of Jackson National Life Insurance Company and Its Affiliates
- Tanishq, India's Top Jewelry Retailer, Expands US Presence with New Texas Stores
Create E-mail Alert Related CategoriesPRNewswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!